Rs 168.75 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Eurepa 0.5mg Tablet, containing Repaglinide, is an oral antidiabetic medication used to manage type 2 diabetes. It works by stimulating the pancreas to release insulin, thus reducing blood sugar levels post-meals. With a rapid onset of action, it is particularly useful for controlling blood glucose spikes. This medication allows for flexible dosing based on individual meal patterns, but it requires careful monitoring to avoid hypoglycemia. Suitable lifestyle changes, such as diet and exercise, are recommended alongside Eurepa for optimal diabetes management. Always follow medical guidance for dosage and administration.
Active Ingredient: Contains Repaglinide 0.5 mg for blood sugar control. Indicated for Type 2 Diabetes: Helps manage blood glucose levels in type 2 diabetes patients. Rapid Onset: Quick action in stimulating insulin release post-meals. Flexible Dosing: Can be adjusted based on individual meal patterns and glucose levels. Hypoglycemia Risk: Common side effect includes low blood sugar, requiring regular monitoring.
EUREPA 0.5MG TABLET aids in lowering blood sugar levels by targeting beta cells in the pancreas, stimulating the release of insulin. Insulin plays a crucial role in reducing blood sugar levels.
Follow your physician's instructions when taking EUREPA 0.5MG TABLET. Swallow the medication with a glass of water. Do not crush or chew the tablet. Your doctor will determine the appropriate dosage and duration of treatment based on your age, body weight, and medical condition.
Pregnancy EUREPA 0.5MG TABLET is not recommended for use in pregnant women. Consult your doctor before taking it. Breastfeeding EUREPA 0.5MG TABLET is not recommended for use in breastfeeding women. Consult your doctor before taking it. Driving and using machines Use EUREPA 0.5MG TABLET with caution. Avoid driving or operating machinery if you experience hypoglycemia. Consult your doctor. Alcohol Use EUREPA 0.5MG TABLET with caution. Avoid alcohol consumption as it may affect the medication's ability to lower blood sugar levels. Consult your doctor for advice. Kidney Use EUREPA 0.5MG TABLET with caution in patients with kidney disease. Consult your doctor before taking it. Liver EUREPA 0.5MG TABLET is generally not recommended in patients with severe liver disease. Use with caution in patients with moderate liver disease. Consult your doctor before taking the medicine. Allergy Do not take EUREPA 0.5MG TABLET if you are allergic to Repaglinide or any ingredients of this medicine. Use in Pediatrics EUREPA 0.5MG TABLET is generally not recommended for use in children and adolescents (under 18 years of age). Consult your doctor before taking. Use in Geriatrics Use EUREPA 0.5MG TABLET with caution in elderly patients above 75 years of age. Consult your doctor before taking.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s